Clinical Trials Directory

Trials / Completed

CompletedNCT06444373

Artificial Intelligence in Lung Cancer Screening

Development of an Artificial Intelligence Model in Lung Cancer Screening for the Diagnosis of Lung Nodules and Risk Stratification in Subjects With Occupational and/or Smoking Exposure

Status
Completed
Phase
Study type
Observational
Enrollment
728 (actual)
Sponsor
Scientific Institute San Raffaele · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

Single-center, non-profit, observational, retrospective study of collection of clinical and amnestic data and images to create, implement and develop a pilot model of an integrated virtual platform.

Detailed description

The project we propose is a study whose objective was to develop an artificial intelligence program integrated into a web-based platform for the optimization of the performance of lung cancer screening for the diagnosis of lung nodules and risk stratification in subjects exposed to environmental carcinogens and/or cigarette smoke. Inclusion criteria: Age \> 50; smokers for at least 20 pack-years (20 cigarillos a day for 20 years) or former heavy smokers if they quit less than 15 years ago; and/or previous professional exposure to asbestos; absence of lung cancer symptoms; who performed lung cancer screening after the year 2000 upon approval of the study by the relevant EC.

Conditions

Timeline

Start date
2022-12-02
Primary completion
2024-05-22
Completion
2024-05-30
First posted
2024-06-05
Last updated
2024-06-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06444373. Inclusion in this directory is not an endorsement.

Artificial Intelligence in Lung Cancer Screening (NCT06444373) · Clinical Trials Directory